Evidence map›Paper›PMID 33357464›Full record

ArticleCell host & microbe2021

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.

H-Heinrich Hoffmann, Francisco J Sánchez-Rivera, William M Schneider, Joseph M Luna, Yadira M Soto-Feliciano, Alison W Ashbrook, Jérémie Le Pen, Andrew A Leal, Inna Ricardo-Lax, Eleftherios Michailidis and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort.The journal of allergy and clinical immunology. Global · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

H-Heinrich HoffmannLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Francisco J Sánchez-RiveraCancer Biology and Genetics, MSKCC New York, NY 10065, USA.
William M SchneiderLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Joseph M LunaLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Yadira M Soto-FelicianoLaboratory of Chromatin Biology & Epigenetics, The Rockefeller University, New York, NY 10065, USA.
Alison W AshbrookLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Jérémie Le PenLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Andrew A LealLaura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016 USA.
Inna Ricardo-LaxLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Eleftherios MichailidisLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Yuan HaoLaura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016 USA.
Ansgar F StenzelLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Avery PeaceLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Johannes ZuberResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria; Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
C David AllisLaboratory of Chromatin Biology & Epigenetics, The Rockefeller University, New York, NY 10065, USA.
Scott W LoweCancer Biology and Genetics, MSKCC New York, NY 10065, USA.
Margaret R MacDonaldLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
John T PoirierLaura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY 10016 USA. Electronic address: john.poirier@nyulangone.org.
Charles M RiceLaboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA. Electronic address: ricec@rockefeller.edu.
Rockefeller University · USMemorial Sloan Kettering Cancer Center · USNew York University · USHeidelberg University · DENYU Langone Health · USResearch Institute of Molecular Pathology · AT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Understanding B cell memory in response to diverse virus infectionsU19AI111825 · NIAID · ROCKEFELLER UNIVERSITY · PI RAVETCH, JEFFREY VICTOR · 2014 to 2023
$26.0M
Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI MUIR, TOM · 2015 to 2024
$17.6M
Virology CoreP01AI138938 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2018 to 2022
$8.4M
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunityR01AI124690 · NIAID · ROCKEFELLER UNIVERSITY · PI Charles M Rice · 2016 to 2026
$8.3M
Type I interferon-stimulated genes and the antiviral immune responseR01AI091707 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2011 to 2020
$5.5M
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biologyR01AI150275 · NIAID · ROCKEFELLER UNIVERSITY · PI Charles M Rice · 2020 to 2026
$4.4M
Functional and Mechanistic Study of Histone Crotonylation in Hematological MalignanciesR01CA204639 · NCI · ROCKEFELLER UNIVERSITY · PI ALLIS, CHARLES DAVID, ARMSTRONG, SCOTT A · 2016 to 2020
$3.5M
Immuno-PET imaging of high-grade neuroendocrine lung tumors using 89Zrrovalpituzumab, a DLL3-targeting monoclonal antibodyR01CA213448 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI POIRIER, JOHN THOMAS, RUDIN, CHARLES M. · 2017 to 2021
$3.1M
A systematic analysis of small RNA interactions during RNA virus infectionsR01AI116943 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2016 to 2020
$3.0M
In search of an HBV cure: novel model systems and targetsR01AI143295 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2019 to 2023
$3.0M
NCI NIH HHS P01 CA196539NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA190261NCI NIH HHS R01 CA204639NCI NIH HHS R01 CA213448NCI NIH HHS T32 CA160001NCI NIH HHS U01 CA213359NIAID NIH HHS F32 AI133910NIAID NIH HHS P01 AI138938NIAID NIH HHS R01 AI091707NIAID NIH HHS R01 AI116943NIAID NIH HHS R01 AI124690NIAID NIH HHS R01 AI143295NIAID NIH HHS R01 AI150275NIAID NIH HHS R03 AI141855NIAID NIH HHS R21 AI142010NIAID NIH HHS R21 AI161212NIAID NIH HHS U19 AI111825
6 · The paper itself

Abstract

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has devastated the global economy and claimed more than 1.7 million lives, presenting an urgent global health crisis. To identify host factors required for infection by SARS-CoV-2 and seasonal coronaviruses, we designed a focused high-coverage CRISPR-Cas9 library targeting 332 members of a recently published SARS-CoV-2 protein interactome. We leveraged the compact nature of this library to systematically screen SARS-CoV-2 at two physiologically relevant temperatures along with three related coronaviruses (human coronavirus 229E [HCoV-229E], HCoV-NL63, and HCoV-OC43), allowing us to probe this interactome at a much higher resolution than genome-scale studies. This approach yielded several insights, including potential virus-specific differences in Rab GTPase requirements and glycosylphosphatidylinositol (GPI) anchor biosynthesis, as well as identification of multiple pan-coronavirus factors involved in cholesterol homeostasis. This coronavirus essentiality catalog could inform ongoing drug development efforts aimed at intercepting and treating coronavirus disease 2019 (COVID-19) and help prepare for future coronavirus outbreaks.

Indexed as

Coronavirus 229E, HumanCoronavirus NL63, HumanCoronavirus OC43, HumanCOVID-19CRISPR-Cas SystemsGenes, ViralHost-Pathogen InteractionsHumansSARS-CoV-2Viral ProteinsViral ProteinscoronavirusCOVID-19CRISPRHCoVHCoV-229EHCoV-NL63HCoV-OC43SARS-CoV-2virus-host interactome

Identifiers

PMID33357464
PMCPMC7833927
OpenAlexW3111731041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.